Phase 4 trial of miltefosine for the treatment of Indian visceral leishmaniasis.
Bhattacharya SK, Sinha PK, Sundar S, Thakur CP, Jha TK, Pandey K, Das VR, Kumar N, Lal C, Verma N, Singh VP, Ranjan A, Verma RB, Anders G, Sindermann H, Ganguly NK.
Bhattacharya SK, et al. Among authors: singh vp.
J Infect Dis. 2007 Aug 15;196(4):591-8. doi: 10.1086/519690. Epub 2007 Jun 29.
J Infect Dis. 2007.
PMID: 17624846
Clinical Trial.